{
    "id": "correct_subsidiary_00091_3",
    "rank": 87,
    "data": {
        "url": "https://www.businesswire.com/news/home/20110414007018/en/Catheter-Connections-Appoints-Michael-Bates-to-its-Board-of-Directors",
        "read_more_link": "",
        "language": "en",
        "title": "Catheter Connections Appoints Michael Bates to its Board of Directors",
        "top_image": "https://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=270808&vid=2",
        "meta_img": "https://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=270808&vid=2",
        "images": [
            "https://www.businesswire.com/images/bwlogo_extreme.png",
            "https://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=270808&vid=2",
            "https://www.businesswire.com/images/icons/icon_search.gif",
            "https://www.businesswire.com/images/icons/icon-close-default.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2011-04-14T21:37:00+00:00",
        "summary": "",
        "meta_description": "Michael Bates joins the board of directors of Catheter Connections, a vascular access medical device company commercializing products that reduce the",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": "https://www.businesswire.com/news/home/20110414007018/en/Catheter-Connections-Appoints-Michael-Bates-to-its-Board-of-Directors",
        "text": "SALT LAKE CITY--(BUSINESS WIRE)--Catheter Connections, Inc., a medical device company specializing in vascular access products designed to protect patients from acquiring infections during periods of intravenous infusion therapy, announced today the appointment of Michael Bates to its Board of Directors. Bates brings more than 30 years of experience in corporate financial management, including contributing to successful investor outcomes at his last four companies, all of which were sold at premium valuations.\n\n“Catheter Connections is bringing to market innovative products that fight costly and potentially fatal catheter related bloodstream infections and I am honored to be part of such an important development,” said Bates. \"I look forward to working with Catheter Connections’ management and board as the company enters its next phase of development.”\n\n“Mike Bates has a long history as leader in the medical device industry, garnering multiple successes in growing young companies. We are delighted to welcome him to our Board of Directors, where his financial insight and expertise will be valuable as we pursue our goals,” said Vicki E. Farrar, CEO of Catheter Connections.\n\nBates currently serves as Director and Audit Committee Chairman for BARRX Medical, and is an active angel investor through the Band of Angels and Life Science Angels. He was Chief Financial Officer of St. Francis Medical Technologies, developer of a minimally invasive device and procedure to treat lumbar spinal stenosis, from 2005 until its sale to Kyphon Inc. in January 2007 for $725 million. Bates previously served as CFO for Silicon Genetics, a bioinformatics company from April of 2000 through to its sale to Agilent Technologies in October 2004. He also served as CFO for Collagen Aesthetics Inc., a publicly traded medical device company that was sold to Inamed Corporation in 1999, and CFO of Penederm Incorporated, a publicly traded specialty pharmaceutical company, which was sold to Mylan Laboratories in 1998.\n\nBates joins a diverse and experienced board of directors, which includes co-founders Vicki E. Farrar, Esq., Donald D. Solomon, Ph.D., and Robert Hitchcock, Ph.D., Guy S. Jordan, Ph.D., and Brian Cummings.\n\nAbout Catheter Connections"
    }
}